T-Spot.Discovery SARS-CoV-2 (ELISPOT)

SARS-CoV-2 (COVID-19) 

The T-SPOT Discovery SARS-CoV-2 assay is a simplified variant of the ELISPOT assay technique. ELISPOT assays are exceptionally sensitive since the target cytokine is captured directly around the secreting cell, before it is diluted in the supernatant, bound by receptors of adjacent cells or degraded. This makes ELISPOT assays much more sensitive than conventional ELISA assays.

HARNESSING THE POWER OF T CELLS

The proprietary T-SPOT technology, derived from the ELISPOT platform, measures immune cell responses at a single cell level. The technology detects T cell activation through cytokine release to assess the patient’s immune system.